Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-020871

Chief Commercial Officer sold 17,000 shares at an average $157.01 ($2,669,218)

  • Chief Commercial Officer acquired 17,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CRUTCHFIELD BRADFORD · Chief Commercial Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-12 Exercise or conversion : show line 1 in the form +17,000 $1.16 $19,720 51,608 D
2021-03-12 Sale : show line 2 in the form −2,100 $154.52 $324,492 49,508 D
2021-03-12 Sale : show line 3 in the form −3,807 $155.54 $592,148 45,701 D
2021-03-12 Sale : show line 4 in the form −3,606 $156.52 $564,404 42,095 D
2021-03-12 Sale : show line 5 in the form −2,211 $157.70 $348,684 39,884 D
2021-03-12 Sale : show line 6 in the form −3,176 $158.85 $504,513 36,708 D
2021-03-12 Sale : show line 7 in the form −2,100 $159.51 $334,977 34,608 D
Open-market sales · 17,000 sh · avg $157.01 · $2,669,218

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-12 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −17,000 $1.16 2027-02-03 17,000 579,000 D
Loading xslF345X03/doc4.xml…